Nature Communications (Jan 2022)

GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models

  • Robert J. Torphy,
  • Yi Sun,
  • Ronggui Lin,
  • Alayna Caffrey-Carr,
  • Yuki Fujiwara,
  • Felix Ho,
  • Emily N. Miller,
  • Martin D. McCarter,
  • Traci R. Lyons,
  • Richard D. Schulick,
  • Ross M. Kedl,
  • Yuwen Zhu

DOI
https://doi.org/10.1038/s41467-021-27658-x
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 16

Abstract

Read online

Immunologically cold tumours don’t respond to immune checkpoint blockade inhibition due to poor recruitment of anti-tumour T cells. Authors show here that melanoma-associated lymphatic endothelial cells express G Protein-Coupled Receptor 182 that scavenges CXCL9 and other chemokines necessary for T cell recruitment.